← Back to Pipeline Dashboard Open Source Medicine Foundation

mRNA-1010

Regulatory Submission Filed

Developer: Moderna  |  Target Disease: Seasonal influenza

Category Resource

Explore licensed vaccines, adverse event reporting data, and history for this disease.

View Seasonal influenza Vaccine Guide →
Development Phase Regulatory Submission Filed Primary Status
Platform Technology mRNA Biologic Architecture
Target Indication Seasonal influenza Pathogen / Antigen
Last Verified 2026-07-10 Tier 1 Multi-Source Checked

Multi-Jurisdiction Regulatory Status

Official licensing, rolling submissions, or authorization status tracked across major health authorities.

Regulatory Authority Status & Details
US FDA Submission Filed Date: 2026-01Company-reported filing; confirm against FDA docket before treating as regulator-confirmed
EMA (Europe) Submission Filed Date: 2026-01
Health Canada Submission Filed Date: 2026-01
TGA (Australia) Submission Filed Date: 2026-01

Scientific Profile & Documentation

Platform Architecture
mRNA
Lead Developer
Moderna
Next Expected Milestone
Regulatory decision(s) pending across filed jurisdictions (company projection)
Analyst & Development Notes
Company-projected timelines frequently slip; treat next-milestone dates as company estimates.

Registered Clinical Trials & Studies

Direct registry links to active, completed, or pivotal registration studies across phases.

No primary ClinicalTrials.gov record linked directly. Study data tracked via regulatory submission filings and peer-reviewed releases.

Milestone Overview

  • Stage Verification
    Regulatory Submission Filed confirmed as of 2026-07-10.
  • Target Milestone
    Regulatory decision(s) pending across filed jurisdictions (company projection)

Vaccine Data Navigator Candidate Profile Registry:

This candidate profile is indexed across all clinical development levels (Preclinical through Phase 1–3, Regulatory Filing, and Licensure) from primary registry databases (ClinicalTrials.gov, WHO ICTRP, FDA CBER, EMA, Health Canada, TGA Australia). Data are updated continuously to track global biologic and vaccine pipelines.